CA1099635A - Atoxic, immunogenic product of tetanus toxin - Google Patents

Atoxic, immunogenic product of tetanus toxin

Info

Publication number
CA1099635A
CA1099635A CA283,802A CA283802A CA1099635A CA 1099635 A CA1099635 A CA 1099635A CA 283802 A CA283802 A CA 283802A CA 1099635 A CA1099635 A CA 1099635A
Authority
CA
Canada
Prior art keywords
tetanus toxin
fragment
atoxic
product
tetanus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA283,802A
Other languages
English (en)
French (fr)
Inventor
Torsten B. Helting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA1099635A publication Critical patent/CA1099635A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA283,802A 1976-07-31 1977-07-29 Atoxic, immunogenic product of tetanus toxin Expired CA1099635A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2634584A DE2634584C3 (de) 1976-07-31 1976-07-31 Atoxisches, immunogenes Produkt aus Tetanus-Toxin
DEP2634584.6 1976-07-31

Publications (1)

Publication Number Publication Date
CA1099635A true CA1099635A (en) 1981-04-21

Family

ID=5984461

Family Applications (1)

Application Number Title Priority Date Filing Date
CA283,802A Expired CA1099635A (en) 1976-07-31 1977-07-29 Atoxic, immunogenic product of tetanus toxin

Country Status (18)

Country Link
JP (1) JPS5326319A (enExample)
AT (1) AT362498B (enExample)
AU (1) AU516191B2 (enExample)
BE (1) BE857373A (enExample)
CA (1) CA1099635A (enExample)
DE (1) DE2634584C3 (enExample)
DK (1) DK342577A (enExample)
EG (1) EG12732A (enExample)
FI (1) FI58500C (enExample)
FR (1) FR2360315A1 (enExample)
GB (1) GB1570958A (enExample)
IE (1) IE45539B1 (enExample)
IL (1) IL52617A (enExample)
IT (1) IT1085660B (enExample)
LU (1) LU77874A1 (enExample)
NL (1) NL7708279A (enExample)
NO (1) NO772704L (enExample)
SE (1) SE7708693L (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200627A (en) 1976-07-31 1980-04-29 Behringwerke Aktiengesellschaft Atoxic, immunogenic product of tetanus toxin
GB8516442D0 (en) * 1985-06-28 1985-07-31 Wellcome Found Cloned antigen

Also Published As

Publication number Publication date
AT362498B (de) 1981-05-25
FR2360315A1 (fr) 1978-03-03
IT1085660B (it) 1985-05-28
IL52617A (en) 1980-12-31
FI58500C (fi) 1981-02-10
FR2360315B1 (enExample) 1980-04-11
AU516191B2 (en) 1981-05-21
AU2738077A (en) 1979-02-01
FI58500B (fi) 1980-10-31
IL52617A0 (en) 1977-10-31
GB1570958A (en) 1980-07-09
SE7708693L (sv) 1978-02-01
DE2634584A1 (de) 1978-02-02
NO772704L (no) 1978-02-01
DK342577A (da) 1978-02-01
NL7708279A (nl) 1978-02-02
LU77874A1 (enExample) 1978-02-02
BE857373A (fr) 1978-02-01
JPS5326319A (en) 1978-03-11
EG12732A (en) 1979-09-30
IE45539L (en) 1978-01-31
DE2634584C3 (de) 1979-11-08
IE45539B1 (en) 1982-09-22
FI772305A7 (enExample) 1978-02-01
ATA563477A (de) 1980-10-15
DE2634584B2 (de) 1979-03-22

Similar Documents

Publication Publication Date Title
Underdown et al. Isolation and characterization of an allergen from short ragweed pollen
Curling et al. A chromatographic procedure for the purification of human plasma albumin
Kandutsch et al. PARTIAL PURIFICATION OF TISSUE ISOANTIGENS FROM A MOUSE SARCOMA1, 2
DK165358C (da) Renset Bordetella pertussis antigen, vaccine indeholdende et sådant antigen og fremgangsmåde til isolering af et sådant ant
US5840700A (en) Methods of producing transfer factor
US5667787A (en) Purification of a pertussis outer membrane protein
EP0011032B1 (en) Method for isolation of hbsag
JP2950970B2 (ja) 百日咳菌からの６９０００ダルトンの抗原性タンパク質の精製方法
EP0175841B1 (en) Method for the production of pertussis component vaccine and combined vaccine of pertussis antigen; diphtheria toxoid and tetanus toxoid
US5045203A (en) Separation of protein antigens of Bordetella bacteria by affinity chromatography
KR970002614B1 (ko) 백일해 내독소의 제거방법, 백일해 톡소이드 및 그 제조방법
US4029765A (en) Derivatives of the tetanus toxin, process for their preparation and agents containing them
CA1099635A (en) Atoxic, immunogenic product of tetanus toxin
Saha et al. Immunochemical studies on liver and erythrocyte catalases from cattle, horse, rabbit and human
KHATTAB et al. Alkaline phosphatase of human and calf small intestine. Purification and immunochemical characterization
CN114805504A (zh) 一种低聚合破伤风类毒素制备方法
Russell et al. Guanidine extraction of streptococcal M protein
Lapresle et al. Immunogenicity of a fragment of human serum albumin
US4200627A (en) Atoxic, immunogenic product of tetanus toxin
US4018885A (en) Steroid-binding globulin and process for preparing it and antibodies thereto
Manski et al. Immunochemical studies on lens protein-protein complexes I. the heterogeneity and structure of complexed α-crystallin
Ferreira et al. Mouse C4 (Ss): three-step purification of its C4c fragment and production of a monospecific antiserum
Stotish et al. Studies of a glycoprotein in the oocysts of Eimeria tenella.
RU2068694C1 (ru) Способ выделения фрагмента с3d компонента с3 комплемента человека
Tanino et al. Humoral Components in Tumor-bearing Animals That Inhibit the Appearance of Immunogenicity on Tumor Cells

Legal Events

Date Code Title Description
MKEX Expiry